PKM and neoplasm: In addition, experiments using xenografts and HT29/PKM2-NLS cells indicated that the Stattic and gefitinib combination therapy reversed nuclear PKM2-induced gefitinib resistance and retarded tumor growth compared to either single drug administration (Fig. 5C).